Fair Value Measurements (Tables)

6 Months Ended

Jul. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:

	Fair Value Measured as of July 31, 2023
	Level 1		Level 2		Level 3		Total
	(in thousands)
Assets
Money market funds	$	2,343	$	—	$	—	$	2,343
Total financial assets	$	2,343	$	—	$	—	$	2,343

	Fair Value Measured as of January 31, 2023
	Level 1		Level 2		Level 3		Total
	(in thousands)
Assets
Money market funds	$	133,979	$	—	$	—	$	133,979
U.S. Treasury securities	—		104,966		—		104,966
Total financial assets	$	133,979	$	104,966	$	—	$	238,945

Schedule of Changes in the Fair Value of the Company's Level 3 Financial Instruments

The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments for the six months ended July 31, 2022:

	Private placement warrant liability		ViriCiti Earnout liability
	(in thousands)
Fair value as of January 31, 2022	$	(25)	$	(5,993)
Change in fair value included in other income (expense), net	(23)		—
Effect of foreign currency translation	—		505
Reclassification of warrants to stockholders’ equity (deficit) due to exercise	48		—
Fair value as of July 31, 2022	$	—	$	(5,488)